A groundbreaking development from Washington University School of Medicine in St. Louis promises to revolutionize the diagnosis of neurodegenerative diseases, offering unprecedented clarity for patients and clinicians. Researchers have developed an artificial intelligence-based blood test capable of accurately distinguishing between major forms of dementia, including Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, and dementia with Lewy bodies.